The National Institutes of Health is joining forces with the tech and pharmaceutical industries to speed the development of new drugs for Parkinson’s disease and identify biomarkers for the debilitating condition. Companies participating in the public-private partnership include Celgene (NSDQ:CELG), GlaxoSmithKline (NYSE:GSK), The Michael J. Fox Foundation for Parkinson’s Research, Pfizer (NYSE:PFE), Sanofi (NYSE:SNY) and Verily. Combined the groups plan to commit $12 million to […]
What is the future of medtech in 2018?
Some of the largest medtech companies showed in 2017 that they are ready to grow through embrace the new healthcare ecosystem. Medical device companies are putting greater emphasis on value-based. They’re putting more attention to clinical and economic research and adopting digital products that incorporate machine learning and data integration. Questions, though, still remain as […]
Onduo taps Glytec’s insulin therapy software as part of virtual diabetes clinic
Glytec has inked a deal with Onduo to integrate the company’s Glucommander Outpatient insulin management software into Onduo’s virtual diabetes clinic. Onduo, a joint venture of Sanofi (NYSE:SNY) and Verily, is reportedly working to develop a platform that brings together medical devices, internal medicine ehr software and support from healthcare experts to help people manage their Type II diabetes. Get the […]
FDA taps Apple, J&J and others for health software pre-cert pilot
The FDA yesterday named the nine companies that will be included in a pilot program to pre-certify healthcare software developers. The program was designed with the hopes of reducing the amount of information the regulatory watchdog requires for review. The companies include Apple (NSDQ:AAPL), Fitbit (NYSE:FIT), Johnson & Johnson (NYSE:JNJ), Pear Therapeutics, Phosphorus, Roche (OTC:RHHBY), Samsung, Tidepool and Verily. […]
Google’s Verily is developing AI-powered heart disease test using retinal images
Google (NSDQ:GOOG) parent Alphabet‘s (NSDQ:GOOGL) Verily is developing a new artificial-intelligence powered test that searches for indicators of heart disease risk present in retina images, according to a new study. The study, which has not yet been peer reviewed but has been published by Cornell University, details a new machine-learning powered system designed by Verily to “discover […]
EnteroMedics inks deal with Verily-GSK JV Galvani Bioelectronics
EnteroMedics (NSDQ:ETRM) said today it inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline (NYSE:GSK) and Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, through which Galvani will use a modified vBloc system for pre-clinical research. St. Paul, Minn.-based said it will receive payments for its development under the agreement, and that it will retain rights, title and […]
Medicxi closes $300m EU growth-stage life sciences fund
Investment group Medicxi said today it closed its $300 million Midicxi Growth 1 fund focused on growth stage companies in European life sciences. The fund is being backed by cornerstone strategic investors Novartis (NYSE:NVS), Verily and the European Investment Fund, and includes most of the institutional LPs that backed the firm’s 1st fund, as well as […]
Verily picks up former FDA commissioner Califf
Former FDA commissioner Dr. Robert Califf said today that he will be joining Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL). Califf said that in addition to his spot at Verily, he will also join Duke University, where he will work with the Duke Clinical Research Institute. Califf will also serve as an adjunct professor of medicine at […]
Shockwave Medical picks up ex-HeartWare CEO Godshall | Personnel Moves – May 11, 2017
Shockwave Medical said today it tapped former HeartWare CEO Doug Godshall as its new prez & CEO. Godshall served as CEO of HeartWare for 10 years until the business was acquired by Medtronic (NYSE:MDT) for $1.1 billion last August, Fremont, Calif.-based Shockwave Medical said. Prior to his time at HeartWare, Godshall held various executive and leadership […]
Verily partners with Duke, Stanford to launch massive “baseline” health study
Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), said today it is launching a 4-year, 10,000-patient study looking to examine how people transition from healthy to sick and to identify additional disease risk factors. The company will partner with Duke University and Stanford Medicine, with enrollments beginning in the coming months. Study participants will also be enrolled […]
Verily launches biosensor-equipped Study Watch for clinical study patient monitoring
Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), today unveiled its Study Watch, a wearable device designed to passively capture health data. The watch, intended to create a method of unobtrusive biosensing, is equipped with multiple sensors, including an electrocardiogram, and can monitor heart rate, electrodermal activity and inertial movements, with a battery life of up […]
MassDevice Network
@MassDevice
LinkedIn
Google+